Regulatory evaluation of prostate volume implants: Pitfalls of a retrospective assessment

Brachytherapy

Volumn 10, Issue 5, 2011, Pages 385-394

  Hagan, Michael P ^a,b   Saleh, Habeeb ^a   Moore, Mary ^c   Williamson, Jeffrey ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Evaluation; Medical event; Prostate; Volume implant

Indexed keywords

ADULT; ADVISORY COMMITTEE; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; DOSIMETRY; EVALUATION; HUMAN; IMAGE ANALYSIS; IMPLANT; IMPLANT REGISTRY; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; ORGANIZATION; PRIORITY JOURNAL; PROSTATE; RETROSPECTIVE STUDY;

BRACHYTHERAPY; HOSPITALS, VETERANS; HUMANS; MALE; PATIENT SAFETY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIOISOTOPES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 80052331535     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2011.01.005     Document Type: Article

References (35)

1. Nag S., Bice W., DeWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 2000, 46:221-230.
2. Crook J.M., Potters L., Stock R.G., et al. Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at risk. Brachytherapy 2005, 4:186-194.
3. Merrick G.S., Butler W.M., Dorsey A.T., et al. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy. Radiat Oncol Investig 1998, 6:182-190.
4. Merrick G.S., Butler W.M., Dorsey A.T., et al. The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys 1999, 44:1111-1117.
5. Vicini F.A., Kini V.R., Edmundson G., et al. A comprehensive review of prostate cancer brachytherapy: Defining an optimal technique. Int J Radiat Oncol Biol Phys 1999, 44:483-491.
6. Taussky D., Austen L., Toi A., et al. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. Int J Radiat Oncol Biol Phys 2005, 62:974-980.
7. American College of Radiology. Practice guideline for transperineal permanent brachytherapy of prostate cancer. 2010. Available at: Accessed February 14, 2010. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/ro/brachy_prostate_cancer.aspx.
8. Merrick G.S., Butler W.M., Wallner K.E., et al. Variability of prostate brachytherapy pre-implant dosimetry: A multi-institutional analysis. Brachytherapy 2005, 4:241-251.
9. Potters L., Wang X.H., Yamada Y. A nomogram to compensate for intraoperative prostate edema during transperineal brachytherapy. Tech Urol 2000, 6:99-103.
10. Anderson L.L. Spacing nomogram for interstitial implants of I125 seeds. Med Phys 1976, 3:48-51.
11. Anderson L.L., Moni J.V., Harrison L.B. A nomograph for permanent implants of palladium-103 seeds. Int J Radiat Oncol Biol Phys 1993, 27:129-135.
12. Wang X.H., Potters L. A theoretical derivation of the nomograms for permanent prostate brachytherapy. Med Phys 2001, 28:683-687.
13. Yu Y., Anderson L.L., Li Z., et al. Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64. Med Phys 1999, 26:2054-2076.
14. Yu Y., Schell M.C. A genetic algorithm for the optimization of prostate implants. Med Phys 1996, 23:2085-2091.
15. Prestidge B, Sanda M, Bice W, et al. RTOG 0232, a phase III study comparing combined external beam radiation and transperineal interstitial permanent brachytherapy with brachytherapy alone for selected patients with intermediate risk prostatic carcinoma. 2003. Available at: http://www.rtog.org/members/protocols/0232/0232.pdf.
16. Thomadsen B., Lin S.W., Laemmrich P., et al. Analysis of treatment delivery errors in brachytherapy using formal risk analysis techniques. Int J Radiat Oncol Biol Phys 2003, 57:1492-1508.
17. Ostrom L.T., Rathbun P., Cumberlin R., et al. Lessons learned from investigations of therapy misadministration events. Int J Radiat Oncol Biol Phys 1996, 34:227-234.
18. Kubo H.D., Glasgow G.P., Pethel T.D., et al. High dose-rate brachytherapy treatment delivery: Report of the AAPM Radiation Therapy Committee Task Group No. 59. Med Phys 1998, 25:375-403.
19. Waterman F.M., Yue N., Corn B.W., et al. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: An analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys 1998, 41:1069-1077.
20. Ali I., Algan O., Thompson S., et al. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy. Phys Med Biol 2009, 54:5595-5611.
21. Solhjem M.C., Davis B.J., Pisansky T.M., et al. Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2004, 60:767-776.
22. Solhjem M.C., Davis B.J., Pisansky T.M., et al. Prostate volume before and after permanent prostate brachytherapy in patients receiving neoadjuvant androgen suppression. Cancer J 2004, 10:343-348.
23. Steggerda M., Schneider C., van Herk M., et al. The applicability of simultaneous TRUS-CT imaging for the evaluation of prostate seed implants. Med Phys 2005, 32:2262-2270.
24. Tanaka O., Hayashi S., Kanematsu M., et al. CT-based postimplant dosimetry of prostate brachytherapy: Comparison of 1-mm and 5-mm section CT. Radiat Med 2007, 25:22-26.
25. Wang J.Z., Mayr N.A., Nag S., et al. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy. Med Phys 2006, 33:1025-1032.
26. Su Y., Davis B.J., Furutani K.M., et al. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: Increased seed number correlates with less variability in prostate dosimetry. Phys Med Biol 2007, 52:3105-3119.
27. Aoki M., Yorozu A., Dokiya T. Evaluation of interobserver differences in postimplant dosimetry following prostate brachytherapy and the efficacy of CT/MRI fusion imaging. Jpn J Radiol 2009, 27:342-347.
28. Aoki M., Yorozu A., Dokiya T. Results of a dummy run of postimplant dosimetry between multi-institutional centers in prostate brachytherapy with 125I seeds. Jpn J Radiol 2009, 27:410-415.
29. Nath R., Bice W.S., Butler W.M., et al. AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: Report of Task Group 137. Med Phys 2009, 36:5310-5322.
30. Bice W.S., Prestidge B.R., Grimm P.D., et al. Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 1998, 41:921-927.
31. Jacobs B.L., Gibbons E.P., Smith R.P., et al. Comparison between real-time intra-operative ultrasound-based dosimetry and CT-based dosimetry for prostate brachytherapy using cesium-131. Technol Cancer Res Treat 2008, 7:463-469.
32. Badiozamani K.R., Wallner K., Cavanagh W., et al. Comparability of CT-based and TRUS-based prostate volumes. Int J Radiat Oncol Biol Phys 1999, 43:375-378.
33. Zelefsky M.J., Worman M., Cohen G.N., et al. Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer. Urology 2010, 76:1138-1142.
34. Malmud LS. Submission of guiding principles for nuclear regulatory commission staff use in formulating medical event criteria for permanent implant brachytherapy procedures. USNRC, Advisory Committee on the Medical Uses of Isotopes. 2005. Available at: Accessed September 20, 2010. http://https://www.nrc.gov/reading-rm/doc-collections/commission/secys/2005/secy2005-0234/attch2.pdf.
35. Bice W.S., Prestidge B.R., Sarosdy M.F. Sector analysis of prostate implants. Med Phys 2001, 28:2561-2567.